STOCK TITAN
  1. Home
  2. Sec-filings
  3. APLT
  4. [EFFECT] Applied Therapeutics, Inc. SEC Filing

[EFFECT] Applied Therapeutics, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 6, 2026
Accession Number: 0001193125-26-035517
Submission Type: POS AM
CIK: 0001697532
Company Name: Applied Therapeutics, Inc.
File Number: 333-278182

Source: View Original Filing on SEC EDGAR

Applied Therapeutics

NASDAQ:APLT

View APLT Stock Overview →

APLT Rankings

#6250 Ranked by Market Cap
N/A Ranked by Dividends

APLT Latest News

Feb 3, 2026
Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics
Jan 29, 2026
Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension
Dec 11, 2025
Cycle Pharmaceuticals to Acquire Applied Therapeutics
Nov 20, 2025
Applied Therapeutics Announces Corporate Updates
Nov 13, 2025
Applied Therapeutics Reports Third Quarter 2025 Financial Results 

APLT Latest SEC Filings

Feb 17, 2026
[SCHEDULE 13G/A] Applied Therapeutics, Inc. Amended Passive Investment Disclosure
Feb 13, 2026
[15-12G] Applied Therapeutics, Inc. SEC Filing
Feb 9, 2026
[EFFECT] Applied Therapeutics, Inc. SEC Filing
Feb 4, 2026
[Form 4] Applied Therapeutics, Inc. Insider Trading Activity
Feb 3, 2026
[Form 4] Applied Therapeutics, Inc. Insider Trading Activity

APLT Stock Data

14.86M
136.08M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK